newsfilter
← Latest News
PR Newswire·

Neuralstem Announces a 1-for-20 Reverse Stock Split

Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced a...